Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA

International Journal of Drug Policy

Volumn 14, Issue 5-6, 2003, Pages 373-379

  Deren, Sherry ^a   Fuller, Crystal ^b   Pouget, Enrique R ^a   Blaney, Shannon ^b   Tortu, Stephanie ^c   Kang, Sung Yeon ^a   McMahon, James M ^a   Andia, Jonny F ^a   Des Jarlais, Don C ^a,d   Johnson, Bruce ^e   Rosenblum, Andrew ^e   Vlahov, David ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

AIDS; HIV; Injection drug use; Pharmacy; Substance use; Syringe access

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG PROGRAM; DRUG USE; EVALUATION; FEMALE; HEALTH SURVEY; HUMAN; INJECTION; LEGAL ASPECT; LOGISTIC REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PHARMACY; PREDICTION; PRIORITY JOURNAL; PURCHASING; SYRINGE; UNITED STATES;

EID: 0242575275     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(03)00137-3     Document Type: Article

References (23)

1. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 11:1955;375-386.
2. Case P., Beckett G.A., Jones T.S. Access to sterile syringes in Maine: Pharmacy practice after the 1993 repeal of the syringe prescription law. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18(Suppl. 1):1998;S94-S101.
3. 2 tests. Biometrics. 10:1954;417-451.
4. Cotton-Oldenburg N.U., Carr P., DeBoer J.M., Collison E.K., Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndromes. 27(2):2001;183-192.
5. Deren S., Oliver-Velez D., Finlinson A., Robles R., Andia J., Colon H.M.et al. Integrating qualitative and quantitative methods: Comparing HIV-related risk behaviours among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse. 38(2):2003;1-24.
6. Des Jarlais D.C., Marmor M., Friedmann P., Titus S., Aviles E., Deren S.et al. HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. American Journal of Public Health. 90(3):2000;352-359.
7. Des Jarlais D.C., McKnight C., Friedmann P. Legal syringe purchases by injection drug users in Brooklyn and Queens, 2000-2001. Journal of the American Pharmaceutical Association. 42:2002;S73-S76.
8. Finkelstein R., Tiger R., Greenwald R., Mukherjee R. Pharmacy syringe sales practices during the first year of expanded syringe availability in New York City 2000-2001. Journal of the American Pharmaceutical Association. 42:2002;S83-S87.
9. Fuller C.M., Ahern J., Vadnai L., Coffin P.O., Galea S., Factor S.H.et al. Impact of increased syringe access: Preliminary findings of injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association. 42:2002;S77-S82.
10. Gostin L.O., Lazzarini Z., Jones T.S., Flaherty K. Prevention of HIV/ AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles. Journal of the American Medical Association. 277(1):1997;53-62.
11. Groseclose S.L., Weinstein B., Jones T.S., Valleroy L.A., Fehrs L.J., Kassler W.J. Impact of increased legal access to needles and syringes on practices of injecting drug users and police officers - Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10(1):1995;82-89.
12. Klein S.J., Harris-Valente K., Candelas A.R., Radigan M., Narcisse-Pean M., Tesoriero J.M.et al. What do pharmacists think about New York State's new non-prescription syringe sale program? Results of a survey. Journal of Urban Health. 78(4):2001;679-689.
13. Lurie, P. (1993). The public-health impact of needle-exchange programs in the United States and abroad: Summary, conclusions, and recommendations. San Francisco, CA: Institute for Health Policy Studies, University of California.
14. Maslow C.B., Friedman S.R., Perlis T.E., Rockwell R., Des Jarlais D.C. Changes in HIV seroprevalence and related behaviours among male injection drug users who do and do not have sex with men: New York City, 1990-1999. American Journal of Public Health. 92(3):2002;382-384.
15. New York State Department of Health. (2001). Part 80 - Rules and regulations on controlled substances [Statutory authority: Public health law article 33, Section 3381 (6)(e)]. Retrieved November 8, 2002 from http://www.health.state.ny.us/nysdoh/hivaids/esap/fullregs.htm.
16. New York State Department of Health, AIDS Institute. (2002). ESAP implementation provider registration update, September 2002. Albany, NY: AIDS Institute.
17. Obadia Y., Feroni I., Perrin V., Vlahov D., Moatti J.P. Syringe vending machine for injection drug users: An experiment in Marseille, France. American Journal of Public Health. 89(12):1999;1852-1854.
18. Penal Law of the State of New York. (2001). Criminally possessing a hypodermic needle 220.45. Binghamton, NY: Gould Publications.
19. Singer M., Baer H.A., Scott G., Horowitz S., Weinstein B. Pharmacy access to syringes among injecting drug users: Follow-up findings from Hartford, Connecticut. Public Health Reports. 113(Suppl. 1):1998;81-89.
20. Tortu, S., McMahon, J., Hamid, R., & Pouget, E. R. (2002). Relationship dynamics and disease risk among drug-using women and their primary male sex partners in New York City. In Proceedings of the XIV International Conference on AIDS, Barcelona, Spain.
21. Valleroy L.A., Weinstein B., Jones T.S., Groseclose S.L., Rolfs R.T., Kassler W.J. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales - Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10(1):1995;73-81.
22. Weiser, B. (2002, 21 November). Judge backs drug users in needle-exchange plans. The New York Times, B4.
23. Wright-De Aguero L., Weinstein B., Jones T.S., Miles J. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practice. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18(Suppl. 1):1998;S102-S110.